Enhanced and selective delivery of enzyme therapy to 9L-glioma tumor via magnetic targeting of PEG-modified, ß-glucosidase- conjugated iron oxide nanoparticles
Jie Zhou,1,* Jian Zhang,2,* Wenxi Gao11Department of Urology, Hubei Hospital of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, People’s Republic of China; 2Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA*Th...
Guardado en:
Autores principales: | Zhou J, Zhang J, Gao W |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c0fe89fcc2914b48890012ae05c16166 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Magnetically Directed Enzyme/Prodrug Prostate Cancer Therapy Based on β-Glucosidase/Amygdalin
por: Zhou J, et al.
Publicado: (2020) -
A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system
por: Lu Y, et al.
Publicado: (2018) -
Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection
por: Wang W, et al.
Publicado: (2012) -
Heterobifunctional PEG ligands for bioconjugation reactions on iron oxide nanoparticles.
por: Maarten Bloemen, et al.
Publicado: (2014) -
Delivery luteolin with folacin-modified nanoparticle for glioma therapy
por: Wu C, et al.
Publicado: (2019)